COVID-19-associated costs and mortality in Germany: an incidence-based analysis from a payer’s perspective
Authors:
Open Access
- 11 March 2024
- journal article
- research article
- Published by Springer Nature in BMC Health Services Research
- Vol. 24 (1) , 1-11
Abstract
Background: This study aims to estimate average COVID-19-associated healthcare costs per capita in Germany from a payer perspective. In addition, insights into COVID-19-associated mortality should be gained. Methods: For this purpose, a retrospective longitudinal analysis using health insurance claims data was performed. Patients affected by COVID-19 in Q1/2021 (investigation group (IG)) were compared to a matched non-COVID-19 control group (CG) (1:1 propensity score matching (PSM)). Mean values of healthcare costs in 2020 and 2021 were computed for both groups and then separated by age and by development of Post-COVID-19 Syndrome (PCS). Group differences were examined using Mann–Whitney U test (α = 0.05). Difference-in-Differences approach (DiD) was used to estimate average cost effects of COVID-19 in 2021. Concerning mortality, the number of deaths in 2021 was compared between IG and CG using χ2 test of independence. Results: A total of 8,014 insurants were included (n = 4,007 per group; n = 536 per group examining PCS patients only). Total healthcare costs varied a lot in the sample, were comparable between IG and CG in 2020, but were significantly higher in the IG in 2021 (DiD estimate = € 1,063 (in total); € 3,242 (PCS group)). This was more pronounced in the older age groups. High hospital costs of a minority of patients were the most influential driver of COVID-19-associated healthcare costs. Mortality was more than doubled in the IG (tripled in patients aged ≥ 60). Conclusions: COVID-19 is associated with significantly increased healthcare costs and mortality, especially in older age groups. The additional development of PCS further increases the costs of COVID-19.Keywords
This publication has 32 references indexed in Scilit:
- The Costs of Long COVIDJAMA Health Forum, 2022
- Management im Gesundheitswesen2022
- Post-COVID syndrome. A case series and comprehensive reviewAutoimmunity Reviews, 2021
- A cost of illness study of COVID-19 patients and retrospective modelling of potential cost savings when administering remdesivir during the pandemic “first wave” in a German tertiary care hospitalInfection, 2021
- A Review of Persistent Post-COVID Syndrome (PPCS)Clinical Reviews in Allergy & Immunology, 2021
- How Many Intensive Care Beds are Justifiable for Hospital Pandemic Preparedness? A Cost-effectiveness Analysis for COVID-19 in GermanyApplied Health Economics and Health Policy, 2021
- Recovering Civility during COVID-192021
- Predictors of mortality in patients with COVID-19–a systematic reviewEuropean Journal of Integrative Medicine, 2020
- Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational studyThe Lancet Respiratory Medicine, 2020
- Cost of illness studies: An aid to decision-making?Health Policy, 1987